Legal & General Group Plc - SYNERGY PHARMACEUTICALS DEL ownership

SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 77 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q3 2014. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q4 2018$4,000
-94.2%
38,418
-5.5%
0.00%
Q3 2018$69,000
-2.8%
40,6340.0%0.00%
Q2 2018$71,000
-15.5%
40,634
-12.0%
0.00%
Q1 2018$84,000
-39.6%
46,187
-25.3%
0.00%
Q4 2017$139,000
-21.0%
61,803
+0.2%
0.00%
Q3 2017$176,000
-29.3%
61,701
+9.5%
0.00%
Q2 2017$249,000
+7.8%
56,358
+13.9%
0.00%
Q1 2017$231,000
-13.2%
49,476
+12.2%
0.00%
Q4 2016$266,000
+91.4%
44,109
+68.1%
0.00%
Q3 2016$139,000
+27.5%
26,236
-10.6%
0.00%
Q2 2016$109,000
+118.0%
29,343
+60.0%
0.00%
Q1 2016$50,000
-51.9%
18,3420.0%0.00%
Q4 2015$104,000
+4.0%
18,3420.0%0.00%
Q3 2015$100,000
-32.4%
18,3420.0%0.00%
Q2 2015$148,000
+82.7%
18,3420.0%0.00%
Q1 2015$81,000
+44.6%
18,3420.0%0.00%
Q4 2014$56,000
+7.7%
18,3420.0%0.00%
Q3 2014$52,00018,3420.00%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q3 2014
NameSharesValueWeighting ↓
Alpine Partners USVI, LLC 152,500$697,0002.61%
Trellus Management Company, LLC 155,800$712,0000.90%
WALL STREET ASSOCIATES 942,200$4,306,0000.40%
BAILARD, INC. 340,500$1,556,0000.30%
Baker Brothers Advisors 2,608,271$11,920,0000.17%
STONERIDGE INVESTMENT PARTNERS LLC 104,158$476,0000.10%
Cambridge Investment Research Advisors, Inc. 449,080$2,052,0000.09%
BTG Pactual Global Asset Management Ltd 33,700$154,0000.03%
HighTower Advisors, LLC 242,001$1,106,0000.03%
BHF Kleinwort Benson Group S.A. 39,000$178,0000.02%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders